IDEAYA Biosciences
Talat A. has extensive experience in clinical development and regulatory strategies within the pharmaceutical and biotechnology sectors. Talat A. currently serves as an Adjunct Professor at the University of the Pacific - Thomas J. Long School of Pharmacy. Previously held positions include Vice President at IDEAYA Biosciences and Astex Pharmaceuticals, Inc. Additionally, Talat A. was the Global Head of Clinical Regulatory Strategies at Vertex Pharmaceuticals and served as Senior Medical Director at Medtronic.
This person is not in the org chart
This person is not in any teams
IDEAYA Biosciences
1 followers
IDEAYA is an oncology-focused precision medicine company. Our teams are committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. We are advancing therapeutics that have the potential to be first-in-class and/or best-in-class, with a primary focus in synthetic lethality – an emerging class of precision medicine targets. IDEAYA is headquartered in South San Francisco, California